Genes Involved in Virulence of the Entomopathogenic Fungus Beauveria Bassiana Chapter 3

Total Page:16

File Type:pdf, Size:1020Kb

Genes Involved in Virulence of the Entomopathogenic Fungus Beauveria Bassiana Chapter 3 A multidisciplinary approach to study virulence of the entomopathogenic fungus Beauveria bassiana towards malaria mosquitoes Claudio A. Valero Jiménez Thesis committee Promotors Prof. Dr B.J. Zwaan Professor of Genetics Wageningen University Prof. Dr W. Takken Personal chair at the Laboratory of Entomology Wageningen University Co-promotors Dr. C.J.M. Koenraadt Assistant professor, Laboratory of Entomology Wageningen University Dr. J.A.L. van Kan Assistant professor, Laboratory of Phytopathology Wageningen University Other members Prof. Dr M.E. Schranz, Wageningen University Dr V.I.D. Ros, Wageningen University Dr M. Rep, University of Amsterdam Prof. Dr J. Eilenberg, University of Copenhagen, Denmark This research was conducted under the auspices of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation A multidisciplinary approach to study virulence of the entomopathogenic fungus Beauveria bassiana towards malaria mosquitoes Claudio A. Valero Jiménez Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr A.P.J. Mol, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Wednesday 21 September 2016 at 4 p.m. in the Aula. Claudio A. Valero Jiménez A multidisciplinary approach to study virulence of the entomopathogenic fungus Beauveria bassiana towards malaria mosquitoes. 131 pages. PhD thesis, Wageningen University, Wageningen, NL (2016) With references, with summary in English ISBN 978-94-6257-854-8 DOI 10.18174/385465 Table of Contents Chapter 1................................................................................................................................7 Introduction Chapter 2..............................................................................................................................17 Genes involved in virulence of the entomopathogenic fungus Beauveria bassiana Chapter 3..............................................................................................................................39 Natural variation in virulence of the entomopathogenic fungus Beauveria bassiana against malaria mosquitoes Chapter 4..............................................................................................................................55 Comparative genomics of Beauveria bassiana: uncovering signatures of virulence against insects Chapter 5..............................................................................................................................85 Experimental evolution to increase the efficacy of the entomopathogenic fungusBeauveria bassiana against malaria mosquitoes: effects on mycelial growth and virulence Chapter 6............................................................................................................................105 General discussion Summary.............................................................................................................................121 Acknowledgements.............................................................................................................125 Curriculum Vitae................................................................................................................127 Educational Statement.......................................................................................................129 Chapter 1 Introduction Introduction Chapter 1 Malaria disease Malaria is a vector-borne disease that causes a great threat to human health. The disease is present throughout the tropics, especially in sub-Saharan Africa. Around 214 million cases were reported in 2015, with an estimated mortality of 438 thousand people in 2014 (World Health Organization, 2015). Of these, around 70% where children under five years of age. Malaria is caused by parasites of the Plasmodium genus, most cases being caused by P. falciparum or P. vivax, and to a lesser extent by P. ovale, P. malariae, and P. knowlesi (White et al., 2014). Malaria parasites are transmitted by female mosquitoes of the genus Anopheles, but only 70 to 80 of more than 480 Anopheles species are able to do so (Manguin et al., 2008). Mosquitoes of the An. gambiae complex are considered the main vectors of human malaria in Africa and the complex is composed of eight species, namely: An. gambiae s.s., An. arabiensis, An. quadriannulatus, An. melas, An. merus, An. bwambae, An. coluzzii and An. amharicus (Coetzee, 2004; Coetzee et al., 2013). Malaria transmission is initiated when an infected female Anopheles mosquito inoculates sporozoites into the subcutaneous tissue of a human host while blood-feeding. From there, sporozoites travel to the liver, where they undergo several transformations and eventually develop into thousands of merozoites. Once merozoites are released in the blood stream, they infect red blood cells and reproduce asexually. A small amount of asexual parasites develops into gametocytes that may be ingested by an Anopheles mosquito during a blood meal (Miller et al., 2002). Gametocytes reproduce sexually inside the mosquito, developing into a motile ookinete that migrates through the midgut wall, and becomes an oocyst on the mosquito’s midgut. The oocyst grows and bursts, releasing sporozoites, which move to the salivary glands of the mosquito. When a mosquito takes a new blood meal, it will infect a new host, thereby repeating the infection cycle (White et al., 2014). Malaria control Presently, the main interventions to control and eliminate malaria are vector control (stop mosquitoes of infecting malaria), chemoprevention (suppression and prevention of infections) and case management (diagnosis and treatment of infections)(World Health Organization, 2015). Currently, the most effective way of eradicating and preventing malaria is achieved by vector control using insecticides (Raghavendra et al., 2011). This is accomplished through the use of Insecticide-Treated bed Nets (ITNs) and/or through Indoor Residual Spraying of insecticides (IRS). ITNs provide a physical and chemical barrier against mosquitoes and can reduce the incidence of malaria transmission, especially since most malaria mosquitoes have a nocturnal biting behaviour. ITNs are coated with pyrethroids that have a very low toxicity to 8 Introduction mammals, a rapid knock-down effect, and long residual activity (Raghavendra et al., 2011). A review on interventions using ITNs has shown that they can avert the number of malaria cases by 62%-78% (Bhatt et al., 2015). IRS is a method of spraying the inside of houses with residual insecticides to kill and repel malaria mosquitoes. Normally, the insecticides are sprayed on the inside walls of houses, and mosquitoes are repelled or killed when in contact with the insecticides, thus preventing the transmission of the disease (Pluess et al., 2010). IRS has also been shown to be very effective in reducing malaria transmission to similar levels as ITNs (Mabaso et al., 2004; Pluess et al., 2010). Insecticide resistance The progress achieved in malaria reduction using ITNs and IRS as vector control tools is challenged by the development of resistance to insecticides by malaria mosquitoes. For instance, pyrethroid resistance is of high concern since it is the only insecticide class allowed for use in ITNs and one of the four classes used in IRS (Hemingway et al., 2004; Ranson et al., 2011; Takken and Knols, 2009). Recent reports indicate that insecticide resistance is widespread across the globe with 60 countries declaring resistance to at least one class of insecticide, and 49 countries reporting resistance for two or more types of insecticide classes (Ranson and Lissenden, 2016; World Health Organization, 2015). Furthermore, long-term studies have shown that insecticides have an effect on the behaviour of mosquitoes by reducing the rate of mosquito entry into houses that result in a shift to outdoor biting and in time of biting (Mathenge et al., 2001; Mbogo et al., 1996; Reddy et al., 2011; Takken, 2002). Therefore, insecticide resistance can possibly impair the important advances accomplished through chemical malaria vector control, and consequently constrain further success. Entomopathogenic fungi: a tool for biological control of mosquitoes Due to the negative implications of insecticide resistance on the success of malaria control, the development of alternative tools for malaria vector control is urgently needed. There are several malaria vector control tools in development that can supplement current control methods (McGraw and O’Neill, 2013; Takken and Knols, 2009). Such tools include the modification of the environment by reducing the breeding habitats of mosquitoes or house improvement to reduce biting incidence (Imbahale et al., 2012; Kirby et al., 2008). Other vector control tools are based on genetic modification of mosquitoes, for example, the release of sterile male mosquitoes to reduce the number of offspring (Lofgren et al., 1974). Another approach is the usage of chemical compounds to attract and repel mosquitoes in a push-pull system which, when coupled with removal trapping, can reduce house entry of mosquitoes (Menger et al., 9 Chapter 1 2014; Okumu et al., 2010). Finally, an additional control tool is biological control that makes use of natural enemies of insects. For instance, predatory fish as well as bacteria such asBacillus thuringiensis var. israelensis can be used to control larval populations (Fillinger and Lindsay, 2006; Kusumawathie
Recommended publications
  • Flavonoid-Modifying Capabilities of the Human Gut Microbiome—An in Silico Study
    nutrients Article Flavonoid-Modifying Capabilities of the Human Gut Microbiome—An In Silico Study Tobias Goris 1,* , Rafael R. C. Cuadrat 2 and Annett Braune 1 1 Research Group Intestinal Microbiology, Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany; [email protected] 2 Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany; [email protected] * Correspondence: [email protected] Abstract: Flavonoids are a major group of dietary plant polyphenols and have a positive health impact, but their modification and degradation in the human gut is still widely unknown. Due to the rise of metagenome data of the human gut microbiome and the assembly of hundreds of thousands of bacterial metagenome-assembled genomes (MAGs), large-scale screening for potential flavonoid-modifying enzymes of human gut bacteria is now feasible. With sequences of characterized flavonoid-transforming enzymes as queries, the Unified Human Gastrointestinal Protein catalog was analyzed and genes encoding putative flavonoid-modifying enzymes were quantified. The results revealed that flavonoid-modifying enzymes are often encoded in gut bacteria hitherto not considered to modify flavonoids. The enzymes for the physiologically important daidzein-to-equol conversion, well studied in Slackia isoflavoniconvertens, were encoded only to a minor extent in Slackia MAGs, but were more abundant in Adlercreutzia equolifaciens and an uncharacterized Eggerthellaceae species. In addition, enzymes with a sequence identity of about 35% were encoded in highly abundant MAGs of uncultivated Collinsella species, which suggests a hitherto uncharacterized daidzein-to-equol potential in these bacteria.
    [Show full text]
  • Gut-Derived Flavonifractor Species Variants Are Differentially Enriched
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.30.890848; this version posted December 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Gut-derived Flavonifractor species variants are 2 differentially enriched during in vitro incubation with 3 quercetin 4 Short Title: Flavonifractor species variants are differentially enriched during incubation with 5 quercetin 6 Gina Paola Rodriguez-Castaño 1*, Federico E. Rey2, Alejandro Caro-Quintero3, Alejandro 7 Acosta-González1 8 1 Engineering Department, La Sabana University, Chia, Colombia 9 2 Department of Bacteriology, University of Wisconsin-Madison, USA 10 3 AGROSAVIA, Centro de Investigación Tibaitatá, Mosquera, Colombia. 11 * Correspondence: 12 Gina Paola Rodriguez-Castaño 13 [email protected] (GRC) 14 15 Abstract 16 Flavonoids are a common component of the human diet with widely reported health- 17 promoting properties. The gut microbiota transforms these compounds affecting the overall 18 metabolic outcome of their consumption. Flavonoid-degrading bacteria are often studied in 19 isolation under culture conditions that do not resemble the conditions in the colon and that bioRxiv preprint doi: https://doi.org/10.1101/2019.12.30.890848; this version posted December 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
    [Show full text]
  • Bioavailability and Metabolic Pathway of Phenolic Compounds Muhammad Bilal Hussain, Sadia Hassan, Marwa Waheed, Ahsan Javed, Muhammad Adil Farooq and Ali Tahir
    Chapter Bioavailability and Metabolic Pathway of Phenolic Compounds Muhammad Bilal Hussain, Sadia Hassan, Marwa Waheed, Ahsan Javed, Muhammad Adil Farooq and Ali Tahir Abstract As potential agents for preventing different oxidative stress-related diseases, phenolic compounds have attracted increasing attention with the passage of time. Intake of fruits, vegetables and cereals in higher quantities is linked with decreased chances of chronic diseases. In plant-based foods, phenolic com- pounds are very abundant. However, bio-accessibility and biotransformation of phenolic compound are not reviewed in these studies; therefore, a detailed action mechanism of phenolic compounds is not recognized. In this article, inclusive concept of different factors affecting the bioavailability of phenolic compounds and their metabolic processes is presented through which phenolic compounds go after ingestion. Keywords: polyphenols, bioavailability, biotransformation, metabolism 1. Introduction In recent past, the awareness of the consumer related to the effect of diet on the health has been improved; therefore, leading to upsurge in the con- sumption of vegetables, cereal based foods and fruits. Numerous studies have suggested the bioactive characteristics of the bioactive moieties, i.e., phenolic compounds. Nonetheless, bioactive claims are made without taking into consid- eration the further modifications to which phenolic compounds are subjected once ingested [1]. Phenolic compounds are the secondary metabolites of plants which consti- tute an important group, i.e., phenylpropanoids. These compounds possess an aromatic ring and various OH groups which are link to it. On the basis of clas- sification, phenolic compounds are prorated into various subgroups. They are grouped as a function of the number of phenolic rings that they contain and the radicals that bind these rings to another one [2, 3].
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,962,800 B2 Mathur Et Al
    USOO89628OOB2 (12) United States Patent (10) Patent No.: US 8,962,800 B2 Mathur et al. (45) Date of Patent: Feb. 24, 2015 (54) NUCLEICACIDS AND PROTEINS AND USPC .......................................................... 530/350 METHODS FOR MAKING AND USING THEMI (58) Field of Classification Search None (75) Inventors: Eric J. Mathur, San Diego, CA (US); See application file for complete search history. Cathy Chang, San Diego, CA (US) (56) References Cited (73) Assignee: BP Corporation North America Inc., Naperville, IL (US) PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this Nolling etal (J. Bacteriol. 183: 4823 (2001).* patent is extended or adjusted under 35 Spencer et al., “Whole-Genome Sequence Variation among Multiple U.S.C. 154(b) by 0 days. Isolates of Pseudomonas aeruginosa J. Bacteriol. (2003) 185: 1316-1325. (21) Appl. No.: 13/400,365 2002.Database Sequence GenBank Accession No. BZ569932 Dec. 17. 1-1. Mount, Bioinformatics, Cold Spring Harbor Press, Cold Spring Har (22) Filed: Feb. 20, 2012 bor New York, 2001, pp. 382-393. O O Omiecinski et al., “Epoxide Hydrolase-Polymorphism and role in (65) Prior Publication Data toxicology” Toxicol. Lett. (2000) 1.12: 365-370. US 2012/O266329 A1 Oct. 18, 2012 * cited by examiner Related U.S. Application Data - - - Primary Examiner — James Martinell (62) Division of application No. 1 1/817,403, filed as (74) Attorney, Agent, or Firm — DLA Piper LLP (US) application No. PCT/US2006/007642 on Mar. 3, 2006, now Pat. No. 8,119,385. (57) ABSTRACT (60) Provisional application No. 60/658,984, filed on Mar. The invention provides polypeptides, including enzymes, 4, 2005.
    [Show full text]
  • A Role for the Hydroxybenzoic Acid Metabolites of Flavonoids And
    A ROLE FOR THE HYDROXYBENZOIC ACID METABOLITES OF FLAVONOIDS AND ASPIRIN IN THE PREVENTION OF COLORECTAL CANCER BY RANJINI SANKARANARAYANAN A dissertation submitted in partial fulfillment of the requirements for the Doctor of Philosophy Major in Pharmaceutical Sciences South Dakota State University 2021 ii DISSERTATION ACCEPTANCE PAGE Ranjini Sankaranarayanan This dissertation is approved as a creditable and independent investigation by a candidate for the Doctor of Philosophy degree and is acceptable for meeting the dissertation requirements for this degree. Acceptance of this does not imply that the conclusions reached by the candidate are necessarily the conclusions of the major department. Gunaje Jayarama, A00137123 Advisor Date Omathanu Perumal Department Head Date Nicole Lounsbery, PhD Director, Graduate School Date iii ACKNOWLEDGEMENTS The completion of this work would not have been possible without the help and contribution of various people who have in their own kind way supported its accomplishment. I would like to express my heart-felt gratitude to my mentor Dr. Jayarama Bhat Gunaje for having skillfully guided me through this project and for having generously extended his support throughout. Dr. Jay has taught me invaluable lessons about honesty, integrity, and listening to your data when it comes to scientific research. He has always been a pillar of support and has also been kind in sharing his many experiences to help me both professionally and personally. I thank him for this. These four years that I spent in the lab with him will be time I will fondly remember and cherish forever. I would like to thank Dr. Joy Scaria (Department of Veterinary & Biomedical Sciences, SDSU) and Dr.
    [Show full text]
  • AVANCES EN ALIMENTACION FUNCIONAL.Pdf
    2 AVANCES EN LA INVESTIGACIÓN DE LA ALIMENTACIÓN FUNCIONAL ANEXO:IJornada CYTEDIBEROFUNSOBRE ALIMENTACIÓNSALUD MEXICO2010 Editor:F.JavierFontechaAlonso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ÍNDICE GENERAL Agradecimientos Introducción …..………………………………………………………….…………….……………….….9 Capítulo 1.
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • Structural and Biochemical Characterization of the Dual Substrate Recognition of the (R)-Selective Amine Transaminase from Aspergillus Fumigatus
    Struktur und Funktion der ersten bakteriellen Chalconisomerase und einer (R)-selektiven Amin-Transaminase I n a u g u r a l d i s s e r t a t i o n zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Ernst-Moritz-Arndt-Universität Greifswald vorgelegt von Maren Thomsen geboren am 23.01.1988 in Itzehoe Greifswald, Dezember 2014 Dekan: Prof. Dr. Klaus Fesser 1. Gutachter: Prof. Dr. Winfried Hinrichs 2. Gutachter: Prof. Dr. Norbert Sträter Tag der Promotion: 25. Februar 2015 Inhaltsverzeichnis Inhaltsverzeichnis Seite 1. Einleitung 1 2. Einleitung zu Chalconisomerasen 2 2.1 Flavonoide 2 2.2 Pflanzliche Chalconisomerasen 3 2.3 Reaktionsmechanismus der pflanzlichen Chalconisomerasen 5 2.4 Degradation der Flavonoide durch die intestinale Mikroflora 6 3. Ergebnisse zur Chalconisomerase aus Eubacterium ramulus 8 3.1 De novo Strukturlösung der bakteriellen CHI mittels SIRAS 8 3.2 Strukturanalyse der bakteriellen CHI aus E. ramulus 8 3.3 Aktives Zentrum und Reaktionsmechanismus 9 3.4 Bedeutung des Lids für die bakterielle CHI 10 3.5 Suche nach Faltungshomologen zur bakteriellen CHI 11 4. Einleitung zu (R)-selektiven Amin-Transaminasen 13 5. Ergebnisse zur (R)-selektiven Amin-Transaminase aus Aspergillus fumigatus 18 5.1 Kristallisation und Röntgendiffraktion der (R)-selektiven Amin-Transaminase 18 5.2 Strukturanalyse der (R)-selektiven Amin-Transaminase 18 5.3 Untersuchungen zur dualen Substraterkennung der (R)-selektiven Amin- Transaminase 20 6. Literatur 22 7. Publikationsliste 28 Einleitung 1. Einleitung Proteine können eine Vielzahl an unterschiedlichen Funktionen ausüben. Darunter fallen Aufgaben wie die Übernahme von Stützfunktionen zum Aufbau des Zytoskeletts, andere übernehmen Transportprozesse und vermitteln den gerichteten Stofftransport in der Zelle.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel Et Al
    USOO8561811 B2 (12) United States Patent (10) Patent No.: US 8,561,811 B2 Bluchel et al. (45) Date of Patent: Oct. 22, 2013 (54) SUBSTRATE FOR IMMOBILIZING (56) References Cited FUNCTIONAL SUBSTANCES AND METHOD FOR PREPARING THE SAME U.S. PATENT DOCUMENTS 3,952,053 A 4, 1976 Brown, Jr. et al. (71) Applicants: Christian Gert Bluchel, Singapore 4.415,663 A 1 1/1983 Symon et al. (SG); Yanmei Wang, Singapore (SG) 4,576,928 A 3, 1986 Tani et al. 4.915,839 A 4, 1990 Marinaccio et al. (72) Inventors: Christian Gert Bluchel, Singapore 6,946,527 B2 9, 2005 Lemke et al. (SG); Yanmei Wang, Singapore (SG) FOREIGN PATENT DOCUMENTS (73) Assignee: Temasek Polytechnic, Singapore (SG) CN 101596422 A 12/2009 JP 2253813 A 10, 1990 (*) Notice: Subject to any disclaimer, the term of this JP 2258006 A 10, 1990 patent is extended or adjusted under 35 WO O2O2585 A2 1, 2002 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS (21) Appl. No.: 13/837,254 Inaternational Search Report for PCT/SG2011/000069 mailing date (22) Filed: Mar 15, 2013 of Apr. 12, 2011. Suen, Shing-Yi, et al. “Comparison of Ligand Density and Protein (65) Prior Publication Data Adsorption on Dye Affinity Membranes Using Difference Spacer Arms'. Separation Science and Technology, 35:1 (2000), pp. 69-87. US 2013/0210111A1 Aug. 15, 2013 Related U.S. Application Data Primary Examiner — Chester Barry (62) Division of application No. 13/580,055, filed as (74) Attorney, Agent, or Firm — Cantor Colburn LLP application No.
    [Show full text]
  • Structure-Aware M. Tuberculosis Functional Annotation
    bioRxiv preprint doi: https://doi.org/10.1101/358986; this version posted June 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Structure-aware M. tuberculosis functional annotation 2 uncloaks resistance, metabolic, and virulence genes 3 4 Running title: Structure-aware M.tb annotation uncloaks key functions 5 6 aSamuel J Modlin, aAfif Elghraoui, aDeepika Gunasekaran, aAlyssa M Zlotnicki, bNicholas A Dillon, aNermeeta 7 Dhillon, aNorman Kuo, aCassidy Robinhold, aCarmela K Chan, bAnthony D Baughn, aFaramarz Valafar* 8 9 a Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, San Diego State University, San Diego, CA 92182 10 b Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN, 55455, USA 11 * Corresponding Author 12 13 14 ABSTRACT Accurate and timely functional genome annotation is essential for translating basic 15 pathogen research into clinically impactful advances. Here, through literature curation and 16 structure-function inference, we systematically update the functional genome annotation of 17 Mycobacterium tuberculosis virulent type strain H37Rv. First, we systematically curated 18 annotations for 589 genes from 662 publications, including 282 gene products absent from 19 leading databases. Second, we modeled 1,711 under-annotated proteins and developed a semi- 20 automated pipeline that captured shared function between 400 protein models and structural 21 matches of known function on protein data bank, including drug efflux proteins, metabolic 22 enzymes, and virulence factors.
    [Show full text]
  • Biocatalytic (De)Carboxylation of Phenolic Compounds: Fundamentals and Applications
    Biocatalytic (De)carboxylation of Phenolic Compounds: Fundamentals and Applications Vom Promotionsausschuss der Technischen Universität Hamburg-Harburg Zur Erlangung des akademisches Grades Doktor der Naturwissenschaften (Dr. rer. nat.) genehmigte Dissertation von Lorenzo Pesci aus Rom 2017 Betreuer: Prof. Dr. Andreas Liese 1. Gutachter: Prof. Andreas Liese 2. Gutachter: Prof. Andrew Torda Datum der mündlichen Prüfung: 12.01.2017 Abstract Carbon dioxide is a pivotal compound in the biotic world of metabolism and in the abiotic world of chemical synthesis. These two worlds can merge, to some extent, when biological catalysts for (de)carboxylations are used to accelerate chemical conversions for industrial applications. A particular set of lyases which display this type of activity on phenolic starting materials belong to microbial degradation pathways. Such enzymes are hydroxybenzoic acid and phenolic acid (de)carboxylases, which catalyze reversible carboxylations and can be differentiated according to their regio-selectivity based on which the carboxylic group is added and removed: ortho and para , for phenolic compounds, and beta , for hydroxycinnamic acids. Because carbon dioxide and its hydrated form, bicarbonate, have considerably low standard Gibbs free energies, the equilibrium of the reactions often lie strongly on the decarboxylation side in physiological conditions. In this work, two ortho - (de)carboxylases and one beta -(de)carboxylase were studied in the reaction directions relevant for application. For ortho -selectivity, dihydroxybenzoic acid (de)carboxylases –from Rhizobium sp. and Aspergillus oryzae – were studied in the synthesis –“up-hill”– direction, which yields salicylic acids from phenols. This reaction resembles the abiotic Kolbe-Schmitt synthesis, which is conducted at elevated temperatures and pressures. Therefore, the establishment of an “enzymatic counterpart” for large scale production is highly desirable in order to achieve efficient CO 2 utilization for chemical synthesis.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]